IDIBAPS is a Catalan public research centre dedicated to translational research in the field of biomedicine. It aims to integrate state of the art basic research and quality clinical research in order to acquire and transfer knowledge regarding the main health problems present in our society, with the final purpose of improving their prevention and treatment. Therefore, innovation and technological progress are essential lines of activity at IDIBAPS. The IDIBAPS task force combines more than 400 researchers and it is situated in a melting pot location for biomedical research, close to the Hospital Clínic of Barcelona, the School of Medicine of the University of Barcelona and the CSIC.
According to the “Scimago Institutions Ranking World Report 2011 – Health Sciences”, the overall IDIBAPS Normalized Impact (NI) during this period was 2.11, meaning that IDIBAPS’ scientific articles are cited more than 2.5 times above the world average in comparison with other institutes during the same time period and in the same subject area. The SIR report shows that the IDIBAPS NI is the highest score amongst the other 26 Spanish institutions with more than 1,000 publications listed in the report. It is worth mentioning that the report also shows that 73% of IDIBAPS’ articles were published in journals in the top 25% by impact factor in their categories and 31% of IDIBAPS’ output has been produced in collaboration with foreign institutions.
The Hospital Clínic of Barcelona’s Blood Disease Unit, led by Dr. Joan Lluís Vives-Corrons who also leads the IDIBAPS research in the field and the ENERCA network about rare diseases, is a growing department with a high clinical and research impact. It offers innovative programs for the prevention of major haemoglobin syndromes and other conditions. The Unit also coordinates national and international initiatives to improve the knowledge about anaemias, specially the rare ones, and the patient management.